Page last updated: 2024-10-26

dipyridamole and Diphtheria

dipyridamole has been researched along with Diphtheria in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Diphtheria: A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borghesan Bosco, A1
Arena, F1

Other Studies

1 other study available for dipyridamole and Diphtheria

ArticleYear
[Therapeutic trials of a new pyrimido-pyrimidine derivative in diphtheric myocarditis].
    La Pediatria, 1970, Volume: 78, Issue:2

    Topics: Anti-Bacterial Agents; Child; Child, Preschool; Diphtheria; Dipyridamole; Female; Humans; Infant; Ma

1970